Omalizumab markedly improves urticaria activity scores and quality of life scores in chronic spontaneous urticaria patients: A real life survey

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase

(2011) Marcus Maurer et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Two Cases of Severe Refractory Chronic Idiopathic Urticaria Treated with Omalizumab

(2010) C Vestergaard et al.   ACTA DERMATO-VENEREOLOGICA

Omalizumab - an effective and safe treatment of therapy-resistant chronic spontaneous urticaria

(2010) A. Groffik et al.   ALLERGY

Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1

(2010) M. Maurer et al.   ALLERGY

EAACI/GA²LEN/EDF/WAO guideline: management of urticaria

(2009) T. Zuberbier et al.   ALLERGY

EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

(2009) T. Zuberbier et al.   ALLERGY

How to assess disease activity in patients with chronic urticaria?

(2008) A. Młynek et al.   ALLERGY

Effect of Anti-IgE (Omalizumab) in Chronic Idiopathic Urticaria (CIU) Patients

(2008) L GOBER et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Treatment of chronic autoimmune urticaria with omalizumab

(2008) Allen P. Kaplan et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY